In a patient with chronic back pain currently taking gabapentin 600 mg twice daily, acetaminophen, and a lidocaine patch, would a short trial of cyclobenzaprine (Flexeril) 5 mg twice daily as needed for 7 days be appropriate for muscle spasm?

Short-Term Cyclobenzaprine for Chronic Back Pain

I would not recommend adding cyclobenzaprine (Flexeril) 5 mg BID PRN for 7 days in this patient with chronic back pain. The evidence does not support skeletal muscle relaxants for chronic pain, and this patient's current regimen should be optimized first.

Why Cyclobenzaprine Is Not Appropriate Here

Cyclobenzaprine is FDA-approved only for acute musculoskeletal conditions and should be used for 2-3 weeks maximum 1. The drug label explicitly states it is "indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions" and "should be used only for short periods (up to two or three weeks)" 1.

For chronic low back pain specifically:

• Strong evidence shows skeletal muscle relaxants are NOT effective for chronic pain 2, 3, 4
• The 2017 American College of Physicians guideline found insufficient evidence for skeletal muscle relaxants in chronic low back pain 3, 4
• A 2022 Bayesian network analysis showed skeletal muscle relaxants only decreased pain intensity in acute (not chronic) low back pain 5
• Multiple guidelines recommend against muscle relaxants for chronic pain due to lack of efficacy and significant adverse effects 6, 7, 8, 9

What You Should Do Instead

1. Optimize Current Gabapentin Dosing First

Your patient is on gabapentin 600 mg BID (1200 mg/day total). The therapeutic range for neuropathic pain is 900-3600 mg/day in divided doses 10, 11. Consider:

• Increasing to 600 mg TID (1800 mg/day) initially
• Can titrate up to 1200 mg TID (3600 mg/day) if tolerated
• Titrate by 300-600 mg every few days as tolerated 11

2. Consider Adding a First-Line Agent

If gabapentin optimization is insufficient, evidence-based options include:

For neuropathic component:

• Duloxetine 30-60 mg daily - moderate evidence for chronic low back pain with small improvements in pain and function 3, 4
• Tricyclic antidepressants (nortriptyline 25-150 mg at bedtime) - strong evidence for neuropathic pain 12, 11

For musculoskeletal component:

• NSAIDs (if not contraindicated) - moderate evidence showing small to moderate pain improvement 3, 4
• Topical diclofenac gel - safer systemic profile than oral NSAIDs 10

3. If Opioids Are Considered

Only after first-line therapies fail and for moderate-to-severe pain:

• Tramadol 50 mg 1-2 times daily, titrate to 100 mg QID (max 400 mg/day) - moderate evidence for chronic low back pain with moderate pain relief and small functional improvement 12, 3, 4
• Tramadol has lower addiction risk than traditional opioids but still requires caution 12

Critical Pitfalls to Avoid

The fact that she received Flexeril in the ED does not justify continued use. Emergency departments often prescribe muscle relaxants for acute exacerbations, but this doesn't translate to appropriateness for chronic pain management.

Common adverse effects of cyclobenzaprine include:

• Sedation and drowsiness (very common)
• Anticholinergic effects (dry mouth, constipation, urinary retention)
• Dizziness and falls risk
• CNS depression - particularly problematic when combined with gabapentin 2, 3, 1

The combination of gabapentin + cyclobenzaprine significantly increases sedation and fall risk, especially concerning in older adults 6, 13.

The Evidence Hierarchy

The 2017 ACP guideline 3, 4 represents the most recent high-quality systematic review specifically addressing chronic low back pain pharmacotherapy. This guideline:

• Found insufficient evidence for skeletal muscle relaxants in chronic pain
• Recommended NSAIDs, duloxetine, or tramadol as evidence-based options
• Noted that skeletal muscle relaxants showed benefit only in acute low back pain (≤4 weeks duration)

The FDA drug label 1 explicitly limits use to acute conditions and 2-3 weeks maximum duration, reinforcing that chronic use lacks supporting evidence.

Bottom Line Algorithm

1. Increase gabapentin to 600 mg TID (if renal function permits)
2. Add duloxetine 30-60 mg daily OR nortriptyline 25 mg at bedtime (titrate up)
3. Consider topical NSAIDs or oral NSAIDs if no contraindications
4. Only if above fail: Consider tramadol 50 mg BID, titrate as needed
5. Refer to pain management if inadequate response to above measures

Do not prescribe cyclobenzaprine for chronic pain - the evidence doesn't support it, and you're adding sedation/fall risk without proven benefit 2, 3, 4, 8, 9.